[Aspergillosis].
Mori
Takeshi
T
Division of Hematology, Department of Internal Medicine, Juntendo University School of Medicine.
D000666:Amphotericin B / Q000008:administration & dosage; D000935:Antifungal Agents / Q000008:administration & dosage; D001228:Aspergillosis / Q000145:classification / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D001230:Aspergillus / Q000302:isolation & purification / Q000472:pathogenicity; D015415:Biomarkers / Q000097:blood; D003937:Diagnosis, Differential; D054714:Echinocandins; D005936:Glucans / Q000097:blood; D006801:Humans; D055666:Lipopeptides; D008074:Lipoproteins / Q000008:administration & dosage; D000077551:Micafungin; D010456:Peptides, Cyclic / Q000008:administration & dosage; D011743:Pyrimidines / Q000008:administration & dosage; D012698:Serologic Tests; D014230:Triazoles / Q000008:administration & dosage; D065819:Voriconazole; D047071:beta-Glucans
D000935:Antifungal Agents; D015415:Biomarkers; D054714:Echinocandins; D005936:Glucans; D055666:Lipopeptides; D008074:Lipoproteins; D010456:Peptides, Cyclic; D011743:Pyrimidines; D014230:Triazoles; D047071:beta-Glucans; C068538:liposomal amphotericin B; D000666:Amphotericin B; C033363:beta-1,3-glucan; D065819:Voriconazole; D000077551:Micafungin